½Å°æÁúȯ ½ÃÀåÁ¶»çº¸°í¼­

½Å°æÁúȯ(Neurodegenerative Disease) Ä«Å×°í¸®¿¡¼­´Â ½Å°æº¯¼º Áúȯ(´Ù¹ß¼º°æÈ­Áõ(MS), Ä¡¸Å, ¾ËÃ÷ÇÏÀ̸Ӻ´, °£Áú µî)À» Á¶»ç ´ë»óÀ¸·Î ÇÑ º¸°í¼­¸¦ ¼Ò°³ÇØ µå¸®°í ÀÖ½À´Ï´Ù. ÁßÃ߽Űæ°è ¾à¹° ÆÄÀÌÇÁ¶óÀÎ ¹× ¿¬±¸°³¹ß °ü·Ã °úÁ¦, ½ÃÀåÀÇ °¡´É¼º µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÑ º¸°í¼­µµ Çѵ¥ ¸ð¾Ò½À´Ï´Ù.

1 - 25 (Àüü: 602°Ç)
½Å°æ°¡¼Ò¼º ½ÃÀå : À¯Çü, ±¸¼º¿ä¼Ò, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Neuroplasticity Market by Type, Component, Application, End User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,484,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æ¼¶À¯Á¾Áõ Ä¡·áÁ¦ ½ÃÀå
Neurofibromatosis Drugs
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ä¡¸Å Ä¡·áÁ¦ ½ÃÀå
Dementia Drugs
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úÁ¹Áß Ä¡·áÁ¦ ½ÃÀå
Stroke Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½ºÆ®·¹½º ½ÃÇè Àåºñ ½ÃÀå
Stress Tests Equipment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úô¼ö¿° ½ÃÀå
Encephalomyelitis
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á°ñ½Å°æÅë Ä¡·á ½ÃÀå(2025-2029³â)
Global Sciatica Treatment Market 2025-2029
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 2,500 £Ü 3,480,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ Ã³¹æ»ó À庮 : Á¶Çöº´
Rx Barriers (US) - Schizophrenia
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 8,000 £Ü 11,138,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Åõ·¿ ÁõÈıº Ä¡·áÁ¦ ½ÃÀå
Tourettes Syndrome Drugs
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °­¹ÚÀå¾Ö Ä¡·áÁ¦ ½ÃÀå
Obsessive-Compulsive Disorder Drugs
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æ±Ù Áúȯ Ä¡·áÇÐ ½ÃÀå
Neuromuscular Disease Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´Ù°èÅë À§ÃàÁõ ½ÃÀå
Multiple System Atrophy
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ±ÙÀ§Ã༺ Ãø»ö °æÈ­Áõ Ä¡·á ½ÃÀå(2025-2029³â)
Global Amyotrophic Lateral Sclerosis Treatment Market 2025-2029
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 2,500 £Ü 3,480,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °æÁ÷ Ä¡·á ½ÃÀå
Spasticity Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÁúȯ Áø´Ü ½ÃÀå
Neurological Disorder Diagnostics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °æµµÀÎÁöÀå¾Ö ½ÃÀå
Mild Cognitive Impairment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇãÇ÷¼º ½Ã½Å°æº´Áõ Ä¡·á ½ÃÀå
Ischemic Optic Neuropathy Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½ÉÀüµµ ºÎÇÏ °Ë»ç ½ÃÀå
ECG Stress Test
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
µà¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD) : KOL(Key Opinion Leader)ÀÇ °ßÇØ
KOL Insight - Duchenne Muscular Dystrophy
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 39,950 £Ü 55,622,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿ø°Ý °£Áú ½ÃÀå
Tele-Epilepsy
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÅë Ä¡·á ½ÃÀå
Neuralgia Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ä¡¸Å Ä¡·á ½ÃÀå
Dementia Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå
Concussion
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,144,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °£Áú Ä¡·á ½ÃÀå : ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Epilepsy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,995 £Ü 6,954,000 (ºÎ°¡¼¼ º°µµ)
´Ù¹ß¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå º¸°í¼­ : ¾à¹°, ¾à¹° À¯Çü, Åõ¿© °æ·Î, À¯Åë ä³Î, Áö¿ªº°(2025-2033³â)
Multiple Sclerosis Therapies Market Report by Drug, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 2,999 £Ü 4,175,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.